Sonja Marcus

Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial

Amy Burd, Ross L. Levine, Amy S. Ruppert et al. · Nature Medicine · 2020 · 192 citations · Full text

Medicine, Genetics, Oncology +17

Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse

Samuel B. Ho, Norbert Bräu, Ramsey Cheung et al. · Clinical Gastroenterology and Hepatology · 2015 · 119 citations

Medicine, Internal Medicine, Psychiatry +12

Entospletinib with decitabine in acute myeloid leukemia with mutant <i>TP53</i> or complex karyotype: A phase 2 substudy of the Beat AML Master Trial

Vu H. Duong, Amy S. Ruppert, Alice S. Mims et al. · Cancer · 2023 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i> -Mutated or <i>KMT2A</i> -Rearranged AML

Joshua F. Zeidner, Tara L. Lin, Rina Li Welkie et al. · Journal of Clinical Oncology · 2025 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed <i>IDH2</i>-mutant AML

Sheng F. Cai, Ying Huang, Jennie Rachel Lance et al. · Blood Advances · 2023 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14